Beimei Pharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Investors
  • 7

Beimei Pharma General Information

Description

Provider and developer of drugs designed for pediatric prescription medicines. The company focuses on the field of chemical prescription drugs for children, and the company's product pipeline is mainly distributed in the respiratory system, anti-infection, nervous system, digestive system and other fields, providing patients with high quality pediatric medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1501, 1502, 1503, 1505, Floor 15 of Unit 1, Building A, Kexing Science Park
  • Keyuan Road, Nanshan High-tech Zone, Nanshan District
  • Shenzhen, Guangdong 518000
  • China
+86 0755
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Room 1501, 1502, 1503, 1505, Floor 15 of Unit 1, Building A, Kexing Science Park
  • Keyuan Road, Nanshan High-tech Zone, Nanshan District
  • Shenzhen, Guangdong 518000
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beimei Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 21-Jul-2023 Completed Generating Revenue
3. Later Stage VC (Series B) 01-Mar-2022 Completed Generating Revenue
2. Later Stage VC (Series A) 26-Jan-2021 $1.48M Completed Generating Revenue
1. Angel (individual) 01-Mar-2019 $1.48M $1.48M Completed Generating Revenue
To view Beimei Pharma’s complete valuation and funding history, request access »

Beimei Pharma Patents

Beimei Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026045047-A1 Cefcapene pivoxil hydrochloride granule and preparation method therefor Pending 26-Aug-2024
WO-2025036496-A1 Oral thin film comprising lurasidone Inactive 17-Aug-2023
WO-2024234674-A1 Pharmaceutical liquid composition, and preparation method therefor and use thereof Inactive 17-May-2023
WO-2024178796-A1 Crisaborole aerosol and preparation method therefor Inactive 01-Mar-2023
WO-2024178795-A1 External aerosol and preparation method therefor Inactive 01-Mar-2023 A61K9/12
To view Beimei Pharma’s complete patent history, request access »

Beimei Pharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jiangsu Aosaikang Pharmaceutical Corporation Minority
Jiangsu Jinqiao Private Equity Fund Management Growth/Expansion Minority
Shenzhen Nanshan Strategic Emerging Industry Investment Government Minority
Shenzhen Lianrun Oriental Equity Investment Fund Management Growth/Expansion Minority
Shenzhen Yifeng Investment Management Enterprise Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Beimei Pharma FAQs

  • When was Beimei Pharma founded?

    Beimei Pharma was founded in 2010.

  • Where is Beimei Pharma headquartered?

    Beimei Pharma is headquartered in Shenzhen, China.

  • What industry is Beimei Pharma in?

    Beimei Pharma’s primary industry is Pharmaceuticals.

  • Is Beimei Pharma a private or public company?

    Beimei Pharma is a Private company.

  • What is the current valuation of Beimei Pharma?

    The current valuation of Beimei Pharma is .

  • What is Beimei Pharma’s current revenue?

    The current revenue for Beimei Pharma is .

  • How much funding has Beimei Pharma raised over time?

    Beimei Pharma has raised $17.2M.

  • Who are Beimei Pharma’s investors?

    Jiangsu Aosaikang Pharmaceutical, Jiangsu Jinqiao Private Equity Fund Management, Shenzhen Nanshan Strategic Emerging Industry Investment, Shenzhen Lianrun Oriental Equity Investment Fund Management, and Shenzhen Yifeng Investment Management Enterprise are 5 of 7 investors who have invested in Beimei Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process